Program

• The Current and Future Role of CT in Liver Cancer Imaging - Dr. Ewoud Smit
• Liver Cancer Diagnosis with MRI - Dr. Benoit Sauer
• CT Volumetry to Plan and Evaluate Percutaneous Treatment of HCC - Dr. Mark Burgmans
• Live Q&A

Why should you attend?

1. To be able to understand the latest advancements in CT imaging of the liver
2. Understanding the strengths and limitations of various MRI sequences for the liver
3. To understand how CT volumetry can help in treatment planning and evaluation points of hepatocellular carcinoma

Moderator & Speaker: Dr. Ewoud Smit, MD, PhD
Radiologist
Radboud University Medical Center
Nijmegen, the Netherlands

Dr. Ewoud Smit is a radiologist at the Radboud University Medical Center with a great interest in Computed Tomography-related research. He received his medical degree from the University of Utrecht and his MSc. in Physics from the University of Groningen. He followed his residency at the University Medical Center in Utrecht, Meander Medisch Centrum in Amersfoort and Radboudumc in Nijmegen. He received his Ph.D. investigating the development of a single acquisition 4D-CT stroke protocol. In general, his research focuses on functional CT and dynamic CTA, in particular in stroke and body imaging. Currently, he is a consultant abdominal radiologist with a special interest in liver imaging.

Presentation Title: The Current and Future Role of CT in Liver Cancer Imaging
This presentation will touch on epidemiological data and the decision tree for liver cancer imaging. MRI is the most preferred imaging modality to diagnose liver cancer. However, there is an important role for CT in the imaging pathway for hepatocellular carcinomas, cholangiocarcinomas and metastases. CT liver cancer imaging may become even more essential, especially where there is the possibility to benefit from the latest CT advancements such as deep-learning reconstruction, subtraction CT, dual-energy. In the future, perfusion CT and multiple phase scans may be used to improve diagnostic confidence and aid treatment decisions.

Speaker: Dr. Benoît Sauer, MD
Radiologist
Medical Imaging Group - MIM, Clinique Sainte Anne
Strasbourg, France

Dr. Benoît Sauer is a radiologist and is responsible for the imaging department in the Sainte-Anne clinic at Strasbourg. Particularly involved in oncology, he is implicated in the association Oncolia which federates almost all private oncologists, radiotherapists and surgeons of the region. He participates in multidisciplinary decision meetings in this field. His work is oriented towards collaboration with clinicians to optimize the treatment of patients suffering from cancer.

Presentation Title: Liver Cancer Diagnosis with MRI
MRI has become the gold standard for liver pathologies assessment. Without irradiation and sometimes without injection of contrast media, this modality allows differentiation between benign and malignant nodules and at the same time evaluation of surrounding organs. The optimization of sequences is the key point, especially in an altered condition such as with an elderly or fragile patient leading to achieving a better diagnosis and permitting appropriate personalized treatment. MRI is both used in the characterization of lesion and follow-up. Tips and tricks of MRI techniques should be considered to guide the clinicians or interventional radiologists in the choice and evaluation of treatments.

Speaker: Dr. Mark Burgmans, MD, PhD
Interventional radiologist
Head of Interventional Radiology
Leiden University Medical Center
Leiden, the Netherlands

Dr. Mark Burgmans is a Dutch interventional radiologist at the Leiden University Medical Center and a staff member at the Technical University Delft. His field of expertise is interventional oncology, in particular thermal tumor ablation, transarterial chemoembolisation, radioembolisation, and percutaneous hepatic perfusion. Dr. Burgmans holds a PhD from the Leiden University (thesis ‘Advancements in minimally invasive image-guided liver therapies’) and is a principal investigator for studies on radiofrequency ablation with adjuvant Holmium radioembolisation, percutaneous hepatic perfusion with immunotherapy and quantitative ablation margin assessment using CT-CT co-registration. He is the current chairman of the Dutch Society of Interventional Radiology and board member of the Dutch Society for Hepatology.

Presentation Title: CT Volumetry to Plan and Evaluate Percutaneous Treatment of HCC
Hepatocellular carcinoma is the third most common cause of cancer related death. Interventional radiology provides minimally-invasive locoregional therapies at different stages of disease. CT volumetry provides valuable information that allows individualized treatment planning and evaluation. The lecture will discuss how CT volumetry can improve outcomes of percutaneous liver tumor treatment.